Healthcare - Sector
PCRX is currently covered by 6 analysts with an average price target of $32.5. This is a potential downside of $3.98 (-10.91%) from yesterday's end of day stock price of $36.48.
Pacira Pharmaceuticals's activity chart (see below) currently has 465 price targets and 340 ratings on display. The stock rating distribution of PCRX is 73.33% BUY, 20% HOLD and 6.67% SELL.
Analysts' price targets on this stock were met 62.69% of the time, taking 288.2 days on average.
Highest price target for PCRX is $38, Lowest price target is $25, average price target is $32.5.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 09-Oct-2026. First documented stock forecast 18-Jan-2013.
Currently out of the existing stock ratings of PCRX, 11 are a BUY (73.33%), 3 are a HOLD (20%), 1 are a SELL (6.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Mar-2017
$36.5
$0.04 (0.11%)
$38
1 months 10 days ago
(09-Oct-2026)
5/9 (55.56%)
$0.19 (0.52%)
743
Buy Since 30-Apr-2020
$33
1 months 11 days ago
(08-Oct-2026)
18/33 (54.55%)
$8.13 (32.69%)
314
Buy Since 08-Oct-2026
$36
$-0.46 (-1.26%)
$25
1 months 11 days ago
(08-Oct-2026)
4/6 (66.67%)
$-0.39 (-1.07%)
656
Sell Since 19-Feb-2025
$36.5
$0.04 (0.11%)
$24
1 months 11 days ago
(08-Oct-2026)
2/4 (50%)
$0.11 (0.30%)
185
Buy Since 07-Nov-2025
$31
$-5.46 (-14.98%)
$32
1 months 12 days ago
(07-Oct-2026)
7/10 (70%)
$5.8 (23.02%)
311
What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on PCRX (Pacira Pharmaceuticals)?
Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?
Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?
Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?